Skip to main content

Table 1 Clinical dataset

From: The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Demographics

 Age

 Gender

 Years of education

Clinical information

 Diagnosis

 Medication use

  Cardiovascular medication

  Dementia medication

  Hormonal medication

  Psychopharmaceuticals

  Other medication

 Comorbidities

  Cardiovascular disorders

  Cardiovascular risk factors

  Cerebrovascular disorders

  Endocrine disorders

  Neurological disorders

  Other cardiac disorders

  Psychiatric disorders

  Somatic disorders

 Family history of dementia

  First-degree relatives

  Second-degree relatives

 Functional impairment rating

Neuropsychological tests

 Memory, preferred test: AVLT

 Language, preferred test: animal fluency

 Attention, preferred test: Trail Making Test A

 Executive functioning, preferred test: Trail Making Test B

 Visuoconstruction, preferred test: Rey complex figure copy

Aβ measure a

 CSF Aβ42 value and local cutoff point

 Amyloid PET SUV and local cutoff point

  1. aAt least one Aβ measure
  2. amyloid-beta, AVLT Auditory Verbal Learning Test, CSF cerebrospinal fluid, PET positron emission tomography, SUV standardized uptake value